subject: Octapharma Ag - Swot Analysis - Market Research Reports On Aarkstore Enterprise [print this page] Octapharma AG - SWOT Analysis company profile is the essential source for top-level company data and information. Octapharma AG - SWOT Analysis examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Octapharma is a privately owned company engaged in the development, production and sale of human proteins in the areas of immunotherapy and coagulation. The group also offers intensive care and emergency medicines. It operates in Europe, North and South Americas, Asia-Pacific and the Middle East. It is headquartered in Lachen, Switzerland and employed about 4,000 people as of December 2009. The group recorded revenues of E1,008.8 million (approximately $1,406.9 million) during the financial year (FY) ended December 2009, an increase of 13.9% over FY2008. The operating profit of the group was E278.3 million (approximately $388.2 million) during FY2009, an increase of 8.7% over FY2008. The net profit of the group was E253.5 million (approximately $353.6 million) in FY2009, an increase of 9.7% over FY2008.
Scope of the Report
- Provides all the crucial information on Octapharma AG required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Octapharma AG in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Octapharma AG
-Data is supplemented with details on Octapharma AG history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Octapharma AG
Reasons to Purchase
- Support sales activities by understanding your customers businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors business structure, strategy and prospects
- Obtain the most up to date company information available
